The Patent Finder

Advanced Biotherapy, Inc.

Also on record
Records under this name other than patents Advanced Biotherapy, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 6 of 6 · Back to Advanced Biotherapy, Inc.

PatentTitleStatus Expires Confidence
US 6,861,056Compositions and methods for treating hyperimmune response in the eye
Lapsed on the fee record
Ended Mar 1, 2017 · From the USPTO record
Lapsed on the fee recordEnded Mar 1, 2017From the USPTO record
US 6,534,059Compositions and methods for treating hyperimmune response in the eye
Lapsed on the fee record
Ended Mar 18, 2015 · From the USPTO record
Lapsed on the fee recordEnded Mar 18, 2015From the USPTO record
US 7,115,263Compositions and methods for treating hyperimmune response in the eye
Lapsed on the fee record
Ended Oct 3, 2014 · From the USPTO record
Lapsed on the fee recordEnded Oct 3, 2014From the USPTO record
US 6,863,890Treatment of AIDS with antibodies to gamma interferon, alpha interferon and TNF-alpha
Term ended
Term ended Feb 26, 2013 · From the USPTO record
Term endedTerm ended Feb 26, 2013From the USPTO record
US 7,462,454Treatment of herpes
Lapsed on the fee record
Ended Dec 9, 2012 · From the USPTO record
Lapsed on the fee recordEnded Dec 9, 2012From the USPTO record
US 7,232,568Compositions and methods for treating hyperimmune response in the eye
Lapsed on the fee record
Ended Jun 19, 2011 · From the USPTO record
Lapsed on the fee recordEnded Jun 19, 2011From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited